Dube Michael P 4
4 · Intellia Therapeutics, Inc. · Filed Jul 3, 2024
Insider Transaction Report
Form 4
Dube Michael P
VP, Chief Accounting Officer
Transactions
- Award
Common Stock
2024-07-01+17,801→ 49,024 total
Footnotes (1)
- [F1]Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.